Compare Helmerich & Payne Inc. Common Stock (HP) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Helmerich & Payne Inc. Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Helmerich & Payne Inc. Common Stock trades at $38.46 (market cap $3.91B), while NeoGenomics Inc. Common Stock trades at $16.83 (market cap $2.14B). The key difference: Helmerich & Payne Inc. Common Stock is the larger of the two by market cap, and Helmerich & Payne Inc. Common Stock pays a 2.56% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Helmerich & Payne Inc. Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| HP | NEO | |
|---|---|---|
Market Cap | $3.91B | $2.14B |
Volume | 800,382 | 2,228,400 |
Sector | Energy | Health |
52-Week High | $47.64 | $19.91 |
52-Week Low | $23.11 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.54B | $2.44B |
Dividend Yield | 2.56% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Helmerich & Payne Inc. Common Stock
Helmerich & Payne, Inc. is a US drilling contractor that designs, builds, and operates high-performance land and offshore drilling rigs for oil and gas producers worldwide.
Read more on HP →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
